The scheme is between NATCO Pharma Ltd, referred to as the demerged company, and NATCO Crop Health Sciences Ltd, the resulting company, along with their respective shareholders and creditors. Shares of Natco Pharma Ltd ended at ₹948, up by ₹20.25, or 2.18%, on the BSE today, March 24.
